Olema Pharmaceuticals OLMA
NASDAQ OLMA
$7.35 +0.08 (+1.10%)
As of: Nov 11, 2026 · 11:30 AM EST

Olema Pharmaceuticals (OLMA) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Olema Pharmaceuticals (OLMA) reported Depreciation & Amortization (CF) of $102,000 for Q2 2026, down 22.7% from $132,000 a year earlier and down 14.3% from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Olema Pharmaceuticals' Depreciation & Amortization (CF) came in at $451,000, down 4.2% year-over-year; for FY2025, it came in at $490,000, up 24.7% from FY2024.

  • Depreciation & Amortization (CF) has increased for four consecutive years, with a five-year compound annual growth rate of 113.7% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $393,000 in FY2024 (+4.2%), $377,000 in FY2023 (+5.6%), $357,000 in FY2022 (+119.0%) and $163,000 in FY2021.
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $43,000 in Q3 2025 and a high of $187,000 in Q4 2025.
  • Year over year, Depreciation & Amortization (CF) gained in five of the last eight quarters, with growth averaging 12.5%.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q1 2022 (growth of 833.3%); the low point was Q3 2025 (a decline of 54.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $119,000 (Q1 2026), $187,000 (Q4 2025) and $43,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Olema Pharmaceuticals 734.94 Mn -1.15 Bn - 94,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 94,000.00
Jun 30, 2026 102,000.00
Mar 31, 2026 119,000.00
Dec 31, 2025 187,000.00
Sep 30, 2025 43,000.00
Jun 30, 2025 132,000.00
Mar 31, 2025 128,000.00
Dec 31, 2024 116,000.00
Sep 30, 2024 95,000.00
Jun 30, 2024 94,000.00
Mar 31, 2024 88,000.00
Dec 31, 2023 88,000.00
Sep 30, 2023 90,000.00
Jun 30, 2023 99,000.00
Mar 31, 2023 100,000.00
Dec 31, 2022 97,000.00
Sep 30, 2022 91,000.00
Jun 30, 2022 85,000.00
Mar 31, 2022 84,000.00
Dec 31, 2021 73,000.00
API Access

Olema Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OLMA&period=max&api_key=YOUR_API_KEY